A study of the distributional characteristics of FMR1 transcript levels in 238 individuals

Human Genetics

Volumn 114, Issue 5, 2004, Pages 439-447

  Allen, Emily G ^a   He, Weiya ^a   Yadav Shah, Maneesha ^a   Sherman, Stephanie L ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; DNA; GLYCINE; RNA; FMR1 PROTEIN, HUMAN; FRAGILE X MENTAL RETARDATION PROTEIN; MESSENGER RNA; NERVE PROTEIN; PRIMER DNA; RNA BINDING PROTEIN;

ALLELE; ANALYSIS OF VARIANCE; ARTICLE; ATAXIA; BLOOD SAMPLING; CONTROLLED STUDY; DATA ANALYSIS; DNA EXTRACTION; FEMALE; FLUORESCENCE ANALYSIS; FRAGILE X SYNDROME; GENDER; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; LINEAR SYSTEM; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REGRESSION ANALYSIS; RNA EXTRACTION; SEQUENCE ANALYSIS; TRINUCLEOTIDE REPEAT; X CHROMOSOME INACTIVATION; COMPARATIVE STUDY; GENE SILENCING; GENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ATAXIA;

ALLELES; ANALYSIS OF VARIANCE; ATAXIA; DNA PRIMERS; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENE SILENCING; HUMANS; MALE; NERVE TISSUE PROTEINS; OVARIAN FAILURE, PREMATURE; REGRESSION ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-BINDING PROTEINS; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 2542507386     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-004-1086-x     Document Type: Article

References (21)

1. Ashley CTJ, Wilkinson KD, Reines D, Warren ST (1993) FMR1 protein: conserved RNP family domains and selective RNA binding. Science 262:563-566
2. Beever C, Lai BP, Baldry SE, Penaherrera MS, Jiang R, Robinson WP, Brown CJ (2003) Methylation of ZNF261 as an assay for determining X chromosome inactivation patterns. Am J Med Genet 120A:439-441
3. Brown WT, Houck GE, Jeziorowska A, Levinson FN, Ding X, Dobkin C, Zhong J, et al (1993) Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. JAMA 270:1569-1575
4. Brunberg JA, Jacquemont S, Hagerman RJ, Berry-Kravis EM, Grigsby J, Leehey MA, Tassone F, Brown WT, Greco CM, Hagerman PJ (2002) Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction. Am J Neuroradiol 23:1757-1766
5. Crawford DC, Acuna JM, Sherman SL (2001) FMR1 and the fragile X syndrome: human genome epidemiology review. Gen Med 3:359-371
6. Feng Y, Zhang F, Lokey LK, Chastain JL, Lakkis L, Eberhart D, Warren ST (1995) Translational suppression by trinucleotide repeat expansion at FMR1. Science 268:731-734
7. Fu YH, Kuhl DP, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, Verkerk AJ, Holden JJ, Fenwick RGJ, Warren ST (1991) Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67:1047-1058
8. Galvao R, Mendes-Soares L, Camara J, Jaco I, Carmo-Fonseca M (2001) Triplet repeats, RNA secondary structure and toxic gain-of-function models for pathogenesis. Brain Res Bull 56:191-201
9. Greco CM, Hagerman RJ, Tassone F, Chudley AE, Del Bigio MR, Jacquemont S, Leehey M, Hagerman PJ (2002) Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain 125:1760-1771
10. Hagerman RJ, Hagerman PJ (2002) The fragile X premutation: into the phenotypic fold. Curr Opin Genet Dev 12:278-283
11. Hagerman RJ, Leehey M, Heinrichs W, Tassone F, Wilson R, Hills J, Grigsby J, Gage B, Hagerman PJ (2001) Intention tremor, Parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 57:127-130
12. Jin P, Zamescu DC, Zhang F, Pearson CE, Lucchesi JC, Moses K, Warren ST (2003) RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila. Neuron 39:739-747
13. Kenneson A, Zhang F, Hagerdorn CH, Warren ST (2001) Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum Mol Genet 10:1449-1454
14. Meadows K, Pettay D, Newman J, Hersey J, Ashley AE, Sherman SL (1996) Survey of the fragile X syndrome and the fragile X E syndrome in a special education needs population. Am J Med Genet 64:425-433
15. Rosser TC, Johnson TR, Warren ST (2002) A cerebellar FMR1 riboCGG binding protein. Am J Hum Genet (Suppl) 71:507
16. Sherman SL (2000) Premature ovarian failure in the fragile X syndrome. Am J Med Genet 97:189-194
17. Tassone F, Hagerman RJ, Taylor AK, Gane LW, Godfrey TE, Hagerman PJ (2000a) Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in fragile X syndrome. Am J Hum Genet 66:6-15
18. Tassone F, Hagerman RJ, Chamberlain WD, Hagerman PJ (2000b) Transcription of the FMR1 gene in individuals with fragile X syndrome. Am J Med Genet (Semin Med Genet) 97: 195-203
19. Tassone F, Hagerman RJ, Taylor AK, Mills JB, Harris SW, Gane LW, Hagerman PJ (2000c) Clinical involvement of the protein expression in individuals with the FMR1 premutation. Am J Med Genet 91:144-152
20. Tilley WD, Marcelli M, McPhaul MJ (1989) Characterization and expression of a cDNA encoding the human androgen receptor. Proc Natl Acad Sci USA 86:327-331
21. Willemsen R, Hoogeveen-Westerfeld M, Reis S, Holstege J, Severijnen LWFN, Nieuwenhuizen IM, Schrier M, Unen L van, Tassone F, Hoogeveen AT, Hagerman PJ, Mientjes EJ, Oostra BA (2003) The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear inclusions; implications for the cerebellar tremor/ataxia syndrome. Hum Mol Genet 12:949-959